|
|
|
| Research status of epidemiology and risk factors of chronic kidney disease |
| GUO Jiaheng1 ZHANG Geng2 YAN Fengqi3 WANG Dongsheng1 DUAN Yongfei4 WU Guojun5 |
1.Xi’an Medical University, Shaanxi Province, Xi’an 710021, China;
2.Department of Urology, the First Affiliated Hospital of the Air Force Medical University, Shaanxi Province, Xi’an 710032, China;
3.Department of Urology, the Second Affiliated Hospital of the Air Force Medical University, Shaanxi Province, Xi’an 710038, China;
4.Medical School of Yan’an University, Shaanxi Province, Yan’an 716000， China; 5.Institute of Urology and Nephrology, Xi’an People’s Hospital, Shaanxi Province, Xi’an 710004, China
|
|
|
|
Abstract Chronic kidney disease (CKD) is one of the major public health problems in the world. The etiology and pathogenesis of CKD are still unclear, and there are obvious geographical and ethnic differences. Because of the hidden onset of CKD, it is easy to be ignored, which brings certain difficulties to the prevention and treatment. China is a high incidence area of CKD, which is one of the major diseases endangering the health of Chinese residents and a major public health problem that needs to be solved urgently. Epidemiological studies have shown that CKD is the result of multiple factors. This article reviews the research results of the epidemiology and related risk factors of CKD, in order to provide help for the future research.
|
|
|
|
|
|
[1] Webster AC，Nagler EV，Morton RL，et al. Chronic Kidney Disease [J]. Lancet，2017，389（10075）：1238-1252.
[2] Stevens PE，Levin A. Evaluation and management of chronic kidney disease：synopsis of the kidney disease：improving global outcomes 2012 clinical practice guideline [J]. Ann Intern Med，2013，158（11）：825-830.
[3] Lv JC，Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease [J]. Adv Exp Med Biol，2019，1165：3-15.
[4] Jha V，Garcia-Garcia G，Iseki K，et al. Chronic kidney disease：global dimension and perspectives [J]. Lancet，2013， 382（9888）：260-272.
[5] Zhang L，Wang F，Wang L，et al. Prevalence of chronic kidney disease in China：a cross-sectional survey [J]. Lancet，2012， 379（9818）：815-822.
[6] Saran R，Robinson B，Abbott KC，et al. US Renal Data System 2019 Annual Data Report：Epidemiology of Kidney Disease in the United States [J]. Am J Kidney Dis，2020，75（1 Suppl 1）：A6-A7.
[7] Johansen KL，Chertow GM，Foley RN，et al. US Renal Data System 2020 Annual Data Report：Epidemiology of Kidney Disease in the United States [J]. Am J Kidney Dis，2021，77 （4）：A7-A8.
[8] Bruck K，Stel VS，Gambaro G，et al. CKD Prevalence Varies across the European General Population [J]. J Am Soc Nephrol，2016，27（7）：2135-2147.
[9] Xie Y，Bowe B，Mokdad AH，et al. Analysis of the Global Burden of Disease study highlights the global，regional，and national trends of chronic kidney disease epidemiology from 1990 to 2016 [J]. Kidney Int，2018，94（3）：567-581.
[10] Liu P，Quinn RR，Lam NN，et al. Progression and Regression of Chronic Kidney Disease by Age Among Adults in a Population-Based Cohort in Alberta，Canada [J]. JAMA Netw Open，2021，4（6）：e2112828.
[11] Carrero JJ，Hecking M，Chesnaye NC，et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease[J]. Nature Reviews Nephrology，2018，14（3）：151-164.
[12] Connaughton DM，Hildebrandt F. Personalized medicine in chronic kidney disease by detection of monogenic mutations [J]. Nephrol Dial Transplant，2020，35（3）：390-397.
[13] Kibria GMA，Crispen R. Prevalence and trends of chronic kidney disease and its risk factors among US adults：An analysis of NHANES 2003-18 [J]. Prev Med Rep，2020，20： 101193.
[14] Okoro RN，Farate VT. The use of nephrotoxic drugs in patients with chronic kidney disease [J]. Int J Clin Pharm，2019， 41（3）：767-775.
[15] Romagnani P，Remuzzi G，Glassock R，et al. Chronic kidney disease [J]. Nat Rev Dis Primers，2017，3（1）：17088.
[16] Alicic RZ，Rooney MT，Tuttle KR. Diabetic Kidney Disease：Challenges，Progress，and Possibilities [J]. Clin J Am Soc Nephrol，2017，12（12）：2032-2045.
[17] Saran R，Li Y，Robinson B，et al. US Renal Data System 2015 Annual Data Report：Epidemiology of Kidney Disease in the United States [J]. Am J Kidney Dis，2016，67（3）：A7-A8.
[18] Garofalo C，Borrelli S，Minutolo R，et al. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population [J]. Kidney Int，2017，91（5）：1224-1235.
[19] Chang H，Lin K，Chang J，et al. Risk Factors for Chronic Kidney Disease in Older Adults with Hyperlipidemia and/or Cardiovascular Diseases in Taipei City，Taiwan：A Community-Based Cross-Sectional Analysis [J]. Int J Environ Res Public Health，2020，17（23）：8763.
[20] Gorostidi M，Sánchez-Martínez M，Ruilope LM，et al. Prevalencia de enfermedad renal crónica en Espa?觡a：impacto de la acumulación de factores de riesgo cardiovascular [J]. Nefrología，2018，38（6）：606-615.
[21] Scales CD，Tasian GE，Schwaderer AL，et al. Urinary Stone Disease：Advancing Knowledge，Patient Care，and Population Health [J]. Clin J Am Soc Nephrol，2016，11（7）：1305-1312.
[22] Khan SR，Pearle MS，Robertson WG，et al. Kidney stones [J]. Nat Rev Dis Primers，2016，2：16008.
[23] Cheungpasitporn W，Rossetti S，Friend K，et al. Treatment effect，adherence，and safety of high fluid intake for the prevention of incident and recurrent kidney stones：a systematic review and meta-analysis [J]. J Nephrol，2016，29（2）：211-219.
[24] Guzzi F，Cirillo L，Roperto RM，et al. Molecular Mechanisms of the Acute Kidney Injury to Chronic Kidney Disease Transition：An Updated View [J]. Int J Mol Sci，2019， 20（19）：4941.
[25] Renaghan AD，Jaimes EA，Malyszko J，et al. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation [J]. Clin J Am Soc Nephrol，2020，15（2）：289-297.
[26] Kim J，Kim Y，Ryoo S，et al. One-Year Progression and Risk Factors for the Development of Chronic Kidney Disease in Septic Shock Patients with Acute Kidney Injury：A Single-Centre Retrospective Cohort Study [J]. J Clin Med，2018，7（12）：554.
[27] Park S，Lee S，Kim Y，et al. Short or Long Sleep Duration and CKD：A Mendelian Randomization Study [J]. J Am Soc Nephrol，2020，31（12）：2937-2947.
[28] Hallan SI，?覫 vrehus MA，Romundstad S，et al. Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway [J]. Kidney Int，2016，90（3）：665-673.
[29] Borrelli S，Provenzano M，Gagliardi I，et al. Sodium Intake and Chronic Kidney Disease [J]. Int J Mol Sci，2020，21（13）：4744.
[30] Rebholz CM，Crews DC，Grams ME，et al. DASH （Dietary Approaches to Stop Hypertension） Diet and Risk of Subsequent Kidney Disease [J]. Am J Kidney Dis，2016，68（6）：853-861.
[31] Li G，Huang J，Wang J，et al. Long-Term Exposure to Ambient PM2.5 and Increased Risk of CKD Prevalence in China [J]. J Am Soc Nephrol，2021，32（2）：448-458.
[32] Makehelwala M，Wei Y，Weragoda SK，et al. Characterization of dissolved organic carbon in shallow groundwater of chronic kidney disease affected regions in Sri Lanka [J]. Sci Total Environ，2019，660：865-875.
[33] Hettithanthri O，Sandanayake S，Magana-Arachchi D，et al. Risk factors for endemic chronic kidney disease of unknown etiology in Sri Lanka：Retrospect of water security in the dry zone [J]. Sci Total Environ，2021，795：148839.
[34] Valcke M，Levasseur M，Soares Da Silva A，et al. Pesticide exposures and chronic kidney disease of unknown etiology：an epidemiologic review [J]. Environ Health，2017，16（1）：49.
[35] Quinteros E，Ribó A，Mejía R，et al. Heavy metals and pesticide exposure from agricultural activities and former agrochemical factory in a Salvadoran rural community [J]. Environ Sci Pollut Res Int，2017，24（2）：1662-1676.
[36] Ferguson R，Leatherman S，Fiore M，et al. Prevalence and Risk Factors for CKD in the General Population of Southwestern Nicaragua [J]. J Am Soc Nephrol，2020，31（7）：1585-1593.
[37] Fischer RSB，Vangala C，Truong L，et al. Early detection of acute tubulointerstitial nephritis in the genesis of Mesoamerican nephropathy [J]. Kidney Int，2018，93（3）：681-690.
[38] Coresh J，Hu JR，Bello AK，et al. Action plan for determining and monitoring the prevalence of chronic kidney disease [J]. Kidney Int Suppl，2017，7（2）：63-70.
[39] Stanifer JW，Kilonzo K，Wang D，et al. Traditional Medicines and Kidney Disease in Low- and Middle-Income Countries：Opportunities and Challenges [J]. Semin Nephrol，2017，37（3）：245-259.
[40] Crump C，Sundquist J，Winkleby MA，et al. Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood：national cohort study [J]. BMJ，2019：l1346.
[41] Barrett PM，Mccarthy FP，Evans M，et al. Hypertensive disorders of pregnancy and the risk of chronic kidney disease：A Swedish registry-based cohort study [J]. PLoS Med，2020， 17（8）：e1003255.
[42] Carney EF. CKD risk factors are associated with increased single-nephron GFR [J]. Nat Rev Nephrol，2017，13（8）：443.
[43] Fisher AL，Nemeth E. Iron homeostasis during pregnancy [J]. Am J Clin Nutr，2017，106（Suppl 6）：1567S-1574S.
[44] Hui D，Hladunewich MA. Chronic Kidney Disease and Pregnancy [J]. Obstet Gynecol，2019，133（6）：1182-1194. |
|
|
|
